
Mesenchymal stem cells (MSCs) are the body’s own repair system. Nature allows MSC cells to deliver a homing signal that helps recruit other stem cells in the body to mobilize and “fix” an injured area. Researchers at Rosalind Franklin University of Medicine have recently reported that MSC Mesenchymal stem cells are much better prepared to begin the body’s natural recovery process. Much more than even the self-repair done by the damaged tissues themselves.
Doctors in Thailand have been extracting MSC cells for stem cell treatments for over 10 years now. The MSC cells are typically drawn out from bone marrow, blood, adipose tissue or dental pulp and then processed and expanded in close system stem cells labs in Bangkok. The MSC+ stem cells are then grafted or delivered via IV drips to the patient to begin the regeneration process. After years of successful treatment, the doctors have developed a distinct protocol that promotes rapid signaling and healing within the patient’s cell populations. Evidence has clearly shown that patients receiving MSC-derived cells recover much more quickly than those who did not receive treatment in Thailand with direct MSC-enriched stem cell grafts.
The key to regenerative medicine and healing today should not hinge on the location of the grafted MSC+ stem cells. The human body already has a natural delivery system that can be used to promote a faster healing process. Researchers have also looked into the overall habits of MSC+ stem cells in a wide array of before and after stem cell treatments, including patients with Diabetes, Crohn’s disease, congestive heart failure, bone defects,cerebral palsy and arthritis or joint/ ligament damage repair. Although MSC+ Stem cells have been known as the magic behind stem cells in the use of regenerative medicine and tissue repair, up until now long term studies had not been completed so doctors and researchers had not been able to discuss exactly how MSC+ stem cells function along with other Multipotent cell lines including neural stem cells, hematopoietic stem cells, pancreatic stem cells, cardiac stem cells and neural progenitor adult stem cell activators.
Our stem cell doctors are finding even more uses for the signaling or “homing” powers of MSC+ cells, which will hopefully eliminate the need for lifelong stem cell injections and enable a truly cell-free treatment protocol that uses only the body’s own cells. We aim to develop new and innovative treatments by using cellular molecules as medications, as an alternative to today’s costly and inefficient pharmaceutical treatments.
Mesenchymal stem cells typically refer to adult stem cells that are derived from several types of tissues in the human body, such as adipose tissue. However, there is still confusion about whether different tissues carry the same type of mesenchymal stem cells from autologous transplants or allogeneic transplants.
MSC cells are short for “Mesenchymal Stromal Cells” and are considered to be multipotent cells that can naturally differentiate themselves into a variety of vital stem cell types with the added feature or “immortality.” Both Muse Cells and MSC cells have the remarkable capacity to self-renew.
Several Types of MSC Stem Cell Lineages
Mesenchymal Stromal Cells have been clinically proven to be able to differentiate in vitro [1] (in the lab) or in vivo (in people) into cell types such as:
Regeneration Center of Thailand offers a unique protocol using MSC stem cells from cord blood, Dental Pulp, Amniotic Membrane, Peripheral Blood and placenta derived MSC stem cells in most of our regenerative medicine programs.
To learn more about MSC+ Stem Cells or to inquire about a specific treatment we offer please contact us today.
[1] ^ Bhonde, Ramesh R, Preethi Sheshadri, Shikha Sharma, and Anujith Kumar. 2013. Making surrogate β-cells from mesenchymal stromal cells: perspectives and future endeavors. The international journal of biochemistry & cell biology (November 22). doi:10.1016/j.biocel.2013.11.006. https://www.ncbi.nlm.nih.gov/pubmed/24275096
[2] ^ Chen, Bei-Yu, Xi Wang, Liang-Wei Chen, and Zhuo-Jing Luo. 2012. Molecular targeting regulation of proliferation and differentiation of the bone marrow-derived mesenchymal stem cells or mesenchymal stromal cells. Current drug targets, no. 4. https://www.ncbi.nlm.nih.gov/pubmed/22443584
[3] ^ Hanson, Summer E, Jaehyup Kim, and Peiman Hematti. 2013. Comparative analysis of adipose-derived mesenchymal stem cells isolated from abdominal and breast tissue. Aesthetic surgery journal, no. 6 ( 1). doi:10.1177/1090820X13496115. https://www.ncbi.nlm.nih.gov/pubmed/23908304
[4] ^ Sharma, Monika B, Lalita S Limaye, and Vaijayanti P Kale. 2011. Mimicking the functional hematopoietic stem cell niche in vitro: recapitulation of marrow physiology by hydrogel-based three-dimensional cultures of mesenchymal stromal cells. Haematologica, no. 5 (November 4). doi:10.3324/haematol.2011.050500. https://www.ncbi.nlm.nih.gov/pubmed/22058199
If you've seen people take ice baths or cold showers and wondered if they're onto… Read More
Immunomodulation stands at the forefront of biomedical research, steering the immune system's ability to fight… Read More
Stem cell research leads the charge in medical innovation, heralding revolutionary advances in regenerative medicine.… Read More
The blood-brain barrier (BBB) is a crucial shield for the brain, regulating the entry of… Read More
While peptide bonds are fundamental to protein structure, their direct relationship with stem cells lies… Read More
When discussing cutting-edge cancer treatments, NK cell therapy stands out for its unique approach to… Read More